EUVIMEDEUVIMED entdecken
Leserbrief

Hypertensive Uveitis After Intravitreal Faricimab: Clinical and Methodological Considerations

Guanghao Qin iD

Clinical & Experimental Ophthalmology · 2026-05 · 54 (4) · 593-594

DOI: 10.1111/ceo.70109 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical & Experimental Ophthalmology, online erschienen am 16.03.2026. Verfasst von Guanghao Qin. Beteiligte Einrichtung: Department of Clinical Research, He Eye Specialist Hospital, Shenyang, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.

Autor:innen und Institutionen

  • Department of Clinical Research, He Eye Specialist Hospital, Shenyang, China.
  • School of Public Health, He University, Shenyang, China.

ORCID-Profile: Guanghao Qin

Zitieren

APA

Qin, G. (2026). Hypertensive Uveitis After Intravitreal Faricimab: Clinical and Methodological Considerations. Clinical & Experimental Ophthalmology, 54(4), 593-594. https://doi.org/10.1111/ceo.70109

Vancouver

Qin G. Hypertensive Uveitis After Intravitreal Faricimab: Clinical and Methodological Considerations. Clinical & Experimental Ophthalmology. 2026;54(4):593-594. doi:10.1111/ceo.70109

BibTeX
@article{Qin2026,
  author = {Qin, Guanghao},
  title = {Hypertensive Uveitis After Intravitreal Faricimab: Clinical and Methodological Considerations},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2026},
  volume = {54},
  number = {4},
  pages = {593--594},
  doi = {10.1111/ceo.70109}
}
Kostenlos starten →